NUDT21 and breast carcinoma: In order to determine whether CFIm25 expression is controlled by miRNAs of interest in breast cancer, we measured the expression levels of potentially involved miRNAs in breast cancer patients (n = 100) and normal adjacent tissues (n = 100) using miR-quantitative qRT–PCR analysis.